Sterile Compounded Products by US Compounding, Inc: Recall - Lack of Sterility Assurance
If the sterility of a compounded preparation intended to be sterile is compromised, patients may be at risk.
Italiano
If the sterility of a compounded preparation intended to be sterile is compromised, patients may be at risk.
FDA revised the labels to indicate that each vial contains Avycaz 2.5 gram, equivalent to ceftazidime 2 gram and avibactam 0.5 gram.
Ultra-rapid metabolizers are more likely to have higher-than-normal amounts of the active form of the opioid in their blood after taking tramadol, which can result in breathing difficulty that may lead to death.
If the device stops pumping, the patient will lose consciousness almost immediately, which can lead to serious injury or death.
Testing has found that these products contain high levels of lead and/or mercury, which can cause serious health problems.
If scope reprocessing procedure is not followed meticulously, the flexible bronchoscope can remain contaminated, potentially resulting in infection transmission from one patient to the next.
Certain preventable advisory alarms may result in patients deciding to attempt a System Controller exchange.
Enhanced labeling explaining how to monitor patients for neutropenia/manage clozapine treatment. Approval of new, shared REMS.
FDA analysis revealing that these dietary supplements contain undeclared drug products making them unapproved drugs.
L'Agenzia Europea per i Medicinali (EMA) ha avviato una rivalutazione
degli spray per uso nasale e orale contenenti l’antibiotico fusafungina,
utilizzato per trattare le infezioni delle vie respiratorie superiori,
come sinusite (infezione dei seni paranasali) e tonsilliti
(infiammazione delle tonsille causate da un'infezione).
80.211.154.110